AI technologies, particularly in the field of image analysis, have exhibited the potential to automate the assessment of Ki67 expression, establishing standardized cutoff values and enhancing the accuracy of Ki67 assessment in the entire tumor area to distinguish normal tissue DCIS from invasive tissue. The gene discussed is MKI67; the disease is ductal breast carcinoma in situ.